|

Standard Prophylactic DLI Clinical Trials

1 actively recruiting trial across 1 location

Also known as: pro-DLI

Pipeline

Phase 1: 1

Top Sponsors

  • University of Arizona1

Indications

  • Acute Undifferentiated Leukemia (AUL)1
  • Acute Lymphoid Leukemia1
  • Chronic Myeloid Leukemia1
  • Non-hodgkin Lymphoma1
  • Myelodysplastic Syndrome1

Tucson, Arizona1 trial

Prophylactic DLI-X for Leukemia Relapse After HCT

The University of Arizona Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.